Psychotic Disorders

Search with Google Search with Bing
Information
Disease name
Psychotic Disorders
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT02407808 Active, not recruiting Phase 1 Cannabinoids, Learning, and Memory February 2015 August 2024
NCT04902066 Active, not recruiting N/A Face Your Fears: Cognitive Behavioural Virtual Reality Therapy for "Paranoia". April 9, 2021 August 2024
NCT06192602 Active, not recruiting N/A Effects of an Acceptance-based Medication Adherence Therapy for Recent-onset Psychosis March 1, 2022 May 31, 2024
NCT05726617 Active, not recruiting N/A Avatar Intervention for the Treatment of Cannabis Use Disorder in Patients With Severe Mental Health Disorders September 24, 2019 December 31, 2024
NCT04695132 Active, not recruiting N/A Illness Management and Recovery- a Cluster Randomized Controlled Trial Within a Forensic Mental Inpatient Setting October 1, 2021 February 1, 2024
NCT04166019 Active, not recruiting N/A Effect of a Peer-led Self-management Program for Recent-onset Psychosis December 1, 2020 June 30, 2024
NCT05872555 Active, not recruiting Side Effects of Psychiatric Medications - a Nested Case Control Cohort Historical Prospective Study March 26, 2023 January 1, 2025
NCT00128505 Completed Phase 3 An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression August 2005 November 2006
NCT00130676 Completed Phase 3 A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression September 2004 June 2006
NCT00130923 Completed Phase 4 Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder September 2005 July 2010
NCT00137020 Completed Phase 4 Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder November 2004 April 2006
NCT00137267 Completed N/A A Brief Community Linkage Intervention for Dually Diagnosed Individuals June 2005 June 2009
NCT00145444 Completed Phase 3 Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study March 2003 November 2005
NCT00158223 Completed Phase 4 Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia October 2004 February 2009
NCT00159770 Completed Phase 3 Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients November 2001 September 2004
NCT00163865 Completed A Pilot Study of Boredom in a Community Sample of Adolescents and a Clinical Sample of Adolescents May 2005 June 2008
NCT00169988 Completed N/A Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms March 2004 April 2007
NCT00174200 Completed N/A Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone December 2004 May 2006
NCT00184418 Completed The Immune System and Psychiatric Disorders January 2005 January 2008
NCT00202306 Completed Phase 4 Indicated Prevention of Psychotic Disorders With Low-dose Lithium November 2001 December 2006
NCT00212797 Completed Phase 2 A Study to Determine the Efficacy and Safety of 2 Doses of Org 34517 as Adjunctive Therapy in Subjects With Psychotic Major Depression (28130)(P05845) July 2004 July 2006
NCT00216476 Completed Phase 3 A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder October 2004 November 2007
NCT00216632 Completed Phase 4 A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™) March 2005 July 2007
NCT00222495 Completed N/A A Comparative Study of New Medications for Psychosis in Adolescents August 2002 August 2006
NCT00224302 Completed Phase 4 Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine August 2005 November 2007
NCT00226278 Completed Phase 2 Safety Study of ORG 34517 for Major Depression With Psychotic Features September 2004 November 2005
NCT00231933 Completed Phase 1 Culturally Responsive Person-Centered Care for Psychosis October 2005 May 2009
NCT00236353 Completed Phase 3 Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder May 2002 December 2003
NCT00236457 Completed Phase 3 A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder November 2000 December 2002
NCT00236548 Completed Phase 3 Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by Injection January 2003
NCT00237796 Completed N/A Functional Rehabilitation of Older Patients With Schizophrenia February 2005 January 2009
NCT00239122 Completed N/A Recovery Therapy Trial June 2000 February 2004
NCT00246259 Completed Phase 4 A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis October 2004 December 2008
NCT00246285 Completed Phase 3 A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia April 2001 December 2006
NCT00249132 Completed Phase 3 A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia July 1991
NCT00249171 Completed Phase 4 A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients June 2001 February 2003
NCT00249223 Completed Phase 3 A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia January 2000 December 2000
NCT00253136 Completed Phase 3 A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia November 1999 December 2000
NCT00253240 Completed Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population September 2004 September 2005
NCT00254813 Completed Phase 3 Fast Titration Of Quetiapine Versus Currently Approved Titration October 2004 September 2005
NCT00255918 Completed Phase 1 Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients March 2004 October 2005
NCT00283517 Completed A Registry of Treatment Adherence for Patients With Schizophrenia September 2003 May 2006
NCT00291200 Completed Enhancing the Prospective Prediction of Psychosis August 2003 February 2009
NCT00299702 Completed Phase 4 Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia February 2006 January 2009
NCT00307203 Completed Phase 4 Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke August 1998 February 2004
NCT00307216 Completed N/A Graduated Recovery Intervention Program for Enhancing Treatment for First-Episode Psychosis April 2006 December 2008
NCT00309413 Completed Phase 2 A Clinical Trial on the Antipsychotic Properties of Cannabidiol March 2006 July 2008
NCT00328276 Completed Phase 2 Sarcosine (N-Methylglycine) Monotherapy for Schizophrenia December 2004 December 2005
NCT00363181 Completed Side Effects of Antipsychotic Medications April 2006 December 2011
NCT00369239 Completed Phase 4 Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis March 2006 November 2007
NCT00377117 Completed Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population Part II May 2006 July 2007
NCT00417482 Completed Phase 4 Antipsychotic Discontinuation in Alzheimer's Disease August 2004 April 2011
NCT00419146 Completed Phase 2/Phase 3 Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants September 2001 April 2004
NCT00420823 Completed Phase 2/Phase 3 A Study of Taurine in Patients With First-episode Psychosis Receiving Antipsychotic Treatment January 2007 December 2010
NCT00455234 Completed Phase 3 Rapid Tranquillization Trial: TREC-India II September 2005 July 2006
NCT00034775 Completed Phase 3 A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia. August 2001 October 2002
NCT00034892 Completed Phase 3 CAFE Comparison of Atypicals in First Episode of Psychosis March 2002 March 2005
NCT00044187 Completed Phase 4 The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder April 2001 September 2003
NCT00105794 Completed N/A Psychiatric Advance Directives for Improved Mental Health Care March 2004 June 2007
NCT00108368 Completed Phase 4 The Effects of Risperidone and Olanzapine on Thinking October 2003 March 2006
NCT00125138 Completed Phase 2 Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease July 2005 April 2008
NCT00128479 Completed Phase 3 A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression September 2004 January 2007
NCT00980252 Completed N/A Medication Adherence in Schizophrenia: Development of a CBT-Based Intervention November 2009 March 2013
NCT00982982 Completed Early Phase 1 Effects of Delta-9-THC and Iomazenil in Healthy Humans February 11, 2009 February 22, 2013
NCT00983476 Completed N/A Web-Based Delivery of MOVE! to Veterans With Serious Mental Illness (SMI) March 2012 June 2015
NCT01041976 Completed Phase 2 Supported Employment: Motivational Enhancement for Entry and Outcome January 2011 September 2015
NCT01094249 Completed Phase 1 A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective Disorder February 2009 April 2009
NCT01313052 Completed Phase 3 Forensic Assertive Community Treatment: An Emerging Model of Service Delivery May 2008 May 2014
NCT01410357 Completed N/A Improving Outcomes for Individuals With Serious Mental Illness and Diabetes July 2011 July 2015
NCT01446328 Completed Phase 4 Bergen Psychosis Project 2 - The Best Intro Study October 2011 December 2017
NCT01512290 Completed N/A Theta Burst Transcranial Magnetic Stimulation as Treatment for Auditory Verbal Hallucinations March 2012 May 2014
NCT01597141 Completed N/A Psychosis: Early Detection, Intervention and Prevention May 2003 December 2014
NCT01610011 Completed N/A Acute Glycine Pharmacodynamic Study July 2010 December 2013
NCT01688765 Completed Longitudinal Multimodal Neuroimaging Studies in Patients With First Episode Psychosis October 17, 2012 September 23, 2022
NCT01739127 Completed Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI November 2012 February 2016
NCT01779440 Completed N/A Decision Support for Smoking Cessation in Young Adults With Severe Mental Illness January 1, 2013 February 22, 2018
NCT01804582 Completed N/A The Family VOICE Study May 2013 March 31, 2016
NCT01828931 Completed N/A Lifestyle Intervention for Diabetes and Weight Management in Psychosis December 2012 November 2015
NCT01853020 Completed Early Phase 1 Cannabinoids and Cerebellar-Motor Functioning December 2012 April 7, 2015
NCT01875861 Completed N/A Monitoring and Management for Metabolic Side Effects of Antipsychotics January 2011 April 2017
NCT01924715 Completed Evaluating the Cost Effectiveness of ISTDP: A Quasi Experimental Study January 2008 March 2009
NCT01981356 Completed Early Phase 1 Acceptance and Commitment Therapy for the Inpatient Treatment of Psychosis September 2014 April 2015
NCT02085447 Completed N/A A Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and Homelessness May 2014 December 2016
NCT02087579 Completed Phase 1 Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants February 2014 December 2014
NCT02097563 Completed Phase 2 Family-Focused Therapy for Youth With Early-Onset Bipolar or Psychotic Disorders June 1, 2014 January 1, 2019
NCT02168166 Completed N/A Short-term Working Memory and Executive Training May 2014 June 2017
NCT02181777 Completed N/A Group Training for Social Skills in Psychosis March 2014 November 30, 2016
NCT02305823 Completed Phase 4 Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis October 2005 May 2014
NCT02342210 Completed N/A Mindfulness Group-based Intervention for Early Psychosis: A Pilot Study May 2015 April 2016
NCT02360566 Completed N/A Participatory Video as a Recovery-Oriented Intervention in Early Psychosis January 2016 December 2016
NCT02391649 Completed N/A Problem-solving-based Bibliotherapy Program for Family Caregivers March 1, 2014 August 30, 2020
NCT02398292 Completed N/A A Multi-modal Approach to Addressing Cardiovascular Risk and Building Resilience in Youths With Psychosis February 2015 July 2016
NCT02427542 Completed Phase 1 Feasibility Trial of CBT for Depersonalisation in Psychosis March 2015 March 2016
NCT02431702 Completed Phase 3 A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform July 8, 2015 November 12, 2019
NCT02474524 Completed N/A Self-Management and Recovery Technology Psychosocial Intervention Trial January 1, 2015 July 2017
NCT02526030 Completed Phase 4 Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-up October 2008 June 2015
NCT02534363 Completed Phase 4 Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up October 2005 January 2013
NCT02566057 Completed N/A Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis July 10, 2014 December 31, 2017
NCT02567032 Completed Early Phase 1 Adult Study Oxytocin - Behavioral October 2010 August 2019
NCT02582736 Completed Antipsychotics and Risk of Hyperglycemic Emergencies April 2012 December 2012
NCT02648321 Completed N/A Motivational Intervention for Physical Activity in Psychosis September 2013 August 2015
NCT02663349 Completed N/A Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness January 2016 July 2019
NCT02739932 Completed Adolescent Mental Health: Canadian Psychiatric Risk and Outcome Study March 2015 August 2021
NCT02748486 Completed N/A Efficacy of Metacognitive Training Single Modules: Jumping to Conclusions and To Empathize... May 2014 August 2015
NCT02769507 Completed N/A Transcranial Brain Stimulation and Its Underlying Neural Mechanisms as a Novel Treatment for Auditory Hallucinations July 2016 March 2020
NCT02782442 Completed N/A Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM) September 1, 2016 March 12, 2022
NCT02782507 Completed Cognitive Therapy for Distressing Visual Hallucinations: A Pilot Study January 2012 December 2013
NCT02787135 Completed N/A Efficacy and Mechanisms of Change of an Emotion-oriented Version of Cognitive-behavioral Therapy for Psychosis May 1, 2016 December 31, 2019
NCT02807688 Completed N/A Physical Co-morbidity, Poor Health Behaviour and Health Promotion in Verona Patients With Functional Psychoses March 2012 March 2014
NCT02822092 Completed Striatal Connectivity and Clinical Outcome in Psychosis July 2016 December 2023
NCT02897167 Completed Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients August 2016 March 2019
NCT02906553 Completed N/A The Role of Nitric Oxide in Cognition in Schizophrenia September 2016 April 2019
NCT02930005 Completed Phase 2 Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders August 7, 2015 October 6, 2016
NCT02968667 Completed Phase 2 The Impact of a Helplessness and Recovery of an Empowerment Intervention on People Diagnosed With Schizophrenia: Findings From a Randomized Controlled Trial November 2015 May 2016
NCT03024203 Completed N/A A Comparison of Cognitive Training Approaches in Psychotic Disorders August 2016 March 2018
NCT03143907 Completed N/A Mindfulness Group-based Intervention for Early Psychosis February 22, 2018 May 31, 2020
NCT03217955 Completed N/A Cognitive Behavioural Therapy- Social Functioning In Adolescence With Recent Onset Schizophrenia May 6, 2014 March 1, 2017
NCT03271242 Completed Implementation of National Guidelines for Treatment of Psychoses June 22, 2016 December 31, 2018
NCT03316664 Completed N/A Assessment of Efficacy of a Psychological Therapy in Inpatients With a Schizophrenic Psychosis June 1, 2018 August 31, 2021
NCT03409393 Completed N/A Feasibility and Relevance of High-Intensity Functional Training in Patients With First-Episode Psychosis January 22, 2018 August 1, 2018
NCT03485339 Completed Substance Misuse To Psychosis for Ketamine (SToP-K) June 12, 2018 April 1, 2020
NCT03497663 Completed N/A VIA Family - Family Based Early Intervention Versus Treatment as Usual September 25, 2017 January 1, 2021
NCT03558529 Completed Feasibility and Acceptability of a Smartphone App to Assess Early Warning Signs of Psychosis Relapse May 1, 2015 April 1, 2018
NCT03583073 Completed N/A Psychosis Screening in Juvenile Justice September 1, 2018 April 30, 2023
NCT03769493 Completed N/A Mobile After-Care Intervention to Support Post-Hospital Transition (MACS) January 16, 2019 October 15, 2019
NCT03800368 Completed N/A Exercise and Overnight Motor Sequence Task December 21, 2016 September 1, 2017
NCT03820362 Completed The Role of Personal Identity in Psychotic Symptoms: a Study With the Repertory Grid Technique February 2016 November 2018
NCT03822416 Completed Phase 2 Treating Smokers With Mental Illness March 1, 2019 May 4, 2020
NCT03869177 Completed N/A Implementation of Family Involvement for Persons With Psychotic Disorders. March 21, 2019 May 30, 2022
NCT03969589 Completed N/A Reproductive Life Planning for Women With Mental Illness July 1, 2019 February 28, 2021
NCT04010747 Completed N/A Pilot Study of Motivational Interviewing for Loved Ones March 1, 2020 April 30, 2022
NCT04180709 Completed N/A CBT to Reduce Insomnia and Improve Social Recovery in Early Psychosis October 30, 2020 July 31, 2023
NCT04304417 Completed The Role of Group Identity on the Community Integration of People With Severe Mental Disorder February 17, 2020 April 1, 2022
NCT04379349 Completed N/A Using Short Message Service as a Means of Clinical Engagement in Early Psychosis January 1, 2018 March 31, 2020
NCT04418570 Completed N/A Hormonal and Inflammatory Biomarkers and Response to Cognitive Remediation in Recent-onset Psychosis July 2016 March 2020
NCT04532034 Completed N/A Facilitating Engagement in Evidence-Based Treatment for Early Psychosis September 1, 2020 March 31, 2023
NCT04546178 Completed N/A Psychotherapy for Psychosis, Adverse Events, and Substance Misuse November 15, 2021 September 30, 2023
NCT04578314 Completed N/A RELATE - Efficacy and Feasibility of a Cognitive Behavioural Module for Distressing Auditory Verbal Hallucinations October 1, 2020 January 29, 2023
NCT04602741 Completed N/A Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider Engagement January 4, 2021 June 1, 2023
NCT04783285 Completed N/A Effect of Individual Cognitive Stimulation at Home in Adults With Psychotic Disorders March 29, 2021 December 31, 2021
NCT04799717 Completed Game-based Telehealth Therapeutic Intervention in First Onset Psychosis August 31, 2021 September 9, 2022
NCT04867447 Completed Prevalence of Traumatic Events and PTSD in Immigrant and Non-immigrant Patients With Psychotic Disorder September 1, 2019 March 1, 2023
NCT04922593 Completed Phase 1 Relative Bioavailability of LY03010 Compared to Listed Drug January 13, 2021 April 15, 2022
NCT05012709 Completed N/A A Study of Dose-response Relationship and the Evidence Based Multisensory Stimulation Intervention March 15, 2012 March 10, 2013
NCT05207982 Completed Phase 1 Weight Management Program for Patients With First Episode Psychosis July 15, 2022 July 5, 2023
NCT05210816 Completed N/A Acceptance and Commitment Therapy (ACT) in Early Psychosis Patients January 1, 2022 September 30, 2022
NCT05308056 Completed Depth of Anesthesia During Electroconvulsive Therapy April 19, 2022 February 6, 2023
NCT05321602 Completed Phase 1 Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder September 8, 2021 October 23, 2022
NCT05633108 Completed A Study Based on the French National Health Insurance Database in Participants With Psychotic Disorders March 30, 2023 September 30, 2023
NCT05742893 Completed N/A Comparison of a Speech-Language Assessment Tool for Pragmatic and Discourse Skills in Schizophrenia Spectrum Disorders March 6, 2023 February 13, 2024
NCT06038786 Completed N/A Resiliency Training on the College Campus July 1, 2018 March 1, 2020
NCT06053346 Completed N/A Partners in Wellness: Evaluation of a Pay for Performance Program for High-Utilizers of Mental Health Services August 1, 2016 July 1, 2023
NCT06077279 Completed N/A HCT Effect Among Patients With Psychotic Disorders November 1, 2022 August 30, 2023
NCT00458367 Completed RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice June 2002 October 2006
NCT00484302 Completed N/A Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and Psychosis September 2007 January 2011
NCT00488319 Completed Phase 3 Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia. June 2007 July 2012
NCT00491569 Completed Phase 2 Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia January 2005 December 2006
NCT00531518 Completed N/A Early Detection and Intervention for the Prevention of Psychosis October 2007 September 2013
NCT00535145 Completed Phase 4 Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease October 2007 February 2009
NCT00567034 Completed Phase 1 Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects December 2006 December 2011
NCT00573287 Completed N/A First Episode Schizophrenia and Cannabis-Related Disorder Study June 2006 December 2011
NCT00576095 Completed Clinical and Biological Characteristics of Psychotic Depression August 2005 June 2012
NCT00621465 Completed N/A Critical Time Intervention in the Transition From Hospital to Community in People With Severe Mental Illness April 2002 October 2007
NCT00677898 Completed N/A A Patient-Centered Approach to Improve Screening for Side Effects of Second Generation Antipsychotics (SGAs) March 2010 June 2013
NCT00691535 Completed Genetics of Symptomatology and Treatment Response in Psychotic Major Depression October 2003
NCT00708994 Completed Early Phase 1 Cannabinoids, Neural Synchrony, and Information Processing February 25, 2008 December 3, 2012
NCT00783185 Completed Phase 1 Dual Diagnosis (Psychosis and Cannabismisuse): Comparison of Specialized Treatment Versus Unspecified Treatment January 2006 January 2010
NCT00790517 Completed Phase 2 Reducing Weight and Diabetes Risk in an Underserved Population (STRIDE) June 2009 December 2014
NCT00806234 Completed Phase 4 Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics January 2009 March 2014
NCT00821600 Completed Phase 1 Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia December 2008 June 2009
NCT00844922 Completed Phase 2 Safety of Org 34517 900 mg in Patients Who Received Org 34517 in a Previous Trial (Study 28133/P05842) September 2005 June 2006
NCT00903916 Completed Effect of Antipsychotics on Appetite Regulation August 2007 March 2012
NCT00914238 Completed N/A Extended Specialized Assertive Intervention for First Episode Psychosis July 2009 October 2016
NCT00919620 Completed N/A Stage-specific Case Management for Early Psychosis June 2009 December 2015
NCT00932529 Completed Phase 4 Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting February 2003 January 2010
NCT00936351 Completed N/A Mindfulness Meditation as a Rehabilitation Strategy for Persons With Schizophrenia December 2007 December 2010
NCT00960219 Completed Phase 2 D-amino Acid Oxidase Inhibition (DAAOI-1) add-on Treatment for Chronic Schizophrenia April 2009 July 2011
NCT04290650 Enrolling by invitation N/A Sleep Disturbances in Patients With Psychotic Symptoms (AkuSleep) September 1, 2020 December 31, 2025
NCT00762866 Enrolling by invitation Psychiatric Genotype/Phenotype Project Repository September 2008 December 2027
NCT05731414 Not yet recruiting N/A Outcomes From Remediation and Behavioural Intervention Techniques March 1, 2023 January 31, 2027
NCT06410508 Not yet recruiting N/A Evaluation of a Brief Intervention to Improve Engagement in Early Intervention Services for Psychosis September 1, 2024 August 1, 2026
NCT04517279 Not yet recruiting N/A Peer Approaches to Substances in Early Psychosis Programs: A Pilot Study of a Peer-Led Intervention August 1, 2023 January 31, 2025
NCT05851950 Recruiting N/A RUFUS - Group Rumination-focused CBT for Negative Symptoms August 1, 2023 July 1, 2026
NCT04730518 Recruiting N/A Yoga-based Group Therapy for In-patients With Schizophrenia Spectrum Disorders January 28, 2021 December 30, 2023
NCT05869409 Recruiting Physical Activity, Psychopathology, and Quality of Life in People With Psychotic or Affective Disorders May 1, 2022 December 1, 2025
NCT06045897 Recruiting N/A EEG Microstates Across At-Risk Mental States May 30, 2023 July 30, 2026
NCT04338152 Recruiting N/A Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial January 15, 2021 June 30, 2026
NCT04282915 Recruiting N/A Reducing Stigma Among Healthcare Providers (RESHAPE-cRCT) February 22, 2022 December 2024
NCT05813080 Recruiting N/A Computer-assisted Risk Evaluation in the Early Detection of Psychotic Disorders May 1, 2023 March 2025
NCT04752449 Recruiting N/A Virtual Cognitive Behavioural Therapy for Psychosis February 1, 2021 October 2023
NCT04370730 Recruiting N/A Dimensional and Developmental Profiles of Psychosis in Children and Adolescents June 2, 2021 October 1, 2026
NCT05973110 Recruiting N/A Examining the Efficacy of a Virtual Reality Cognitive Remediation Program for People Living With Psychosis July 31, 2023 February 2026
NCT05597579 Recruiting Cognitive Impairments in Psychotic Disorders February 12, 2020 May 1, 2024
NCT06186570 Recruiting N/A Efficacy of an Online-Based Self-Help Intervention for Auditory Hallucinations in Persons With Psychotic Disorders June 13, 2024 December 15, 2025
NCT04911010 Recruiting N/A Effectiveness of Trauma Therapy in Patients With PTSD and Comorbid Psychotic Disorder January 20, 2021 September 2025
NCT05656469 Recruiting N/A Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders February 23, 2023 March 2025
NCT05686772 Recruiting Prospective Multicenter Cohort Study Evaluating the Incidence and Risk Factors for Problem Gambling Among Young Adults With First-episode Psychosis November 1, 2019 May 1, 2024
NCT05703698 Recruiting N/A EEG Outcomes From Cognitive Behavioural Therapy for Psychosis February 2023 September 2023
NCT05704582 Recruiting N/A RCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders February 1, 2023 January 2028
NCT03873922 Recruiting N/A Ketogenic Diet for Psychotic Disorders March 15, 2021 December 31, 2025
NCT05982158 Recruiting N/A Avatar-mediated Therapy Versus Cognitive Behavioural Therapy for Persisting Experiences of Hearing Voices September 1, 2023 December 2025
NCT06005766 Recruiting N/A The Efficacy of Metacognitive Skills Training in the Context of Forensic Psychiatric Care September 1, 2023 December 2026
NCT04118283 Recruiting N/A Assessment and Treatment for Chronic Pain in Veterans With Serious Mental Illness March 18, 2021 January 31, 2025
NCT02874573 Recruiting Phase 1 Tocilizumab in Schizophrenia September 2016 December 31, 2023
NCT06360562 Recruiting N/A Reconnecting to Ourselves and Others in Virtual Meetings (ROOM) September 15, 2020 April 25, 2025
NCT06038955 Recruiting N/A Effect of Immersive Virtual Reality-based Cognitive Remediation in Patients With Mood - or Psychosis Spectrum Disorders October 1, 2022 June 1, 2025
NCT06384755 Recruiting N/A Honest Open Proud for Psychotic and Bipolar Disorder in Norway April 20, 2024 December 31, 2026
NCT05899348 Recruiting N/A iTEST: Introspective Accuracy as a Novel Target for Functioning in Psychotic Disorders October 1, 2023 February 1, 2025
NCT05945277 Recruiting N/A Critical Time Intervention-Peer Support July 1, 2023 December 31, 2025
NCT04586868 Recruiting N/A VR-assisted CBT for Adolescents With Psychosis June 1, 2020 December 2024
NCT05962879 Recruiting N/A Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness March 22, 2024 July 31, 2027
NCT04610697 Recruiting N/A Cognitive Remediation in Forensic Mental Health Care February 10, 2020 February 10, 2025
NCT04631939 Recruiting N/A Metacognitive Training as a Serious Game June 1, 2021 December 2023
NCT06086184 Recruiting N/A Inpatient Group Acceptance and Commitment Therapy (ACT) for Psychosis Spectrum Disorder October 16, 2023 February 2025
NCT02796859 Recruiting Phase 1/Phase 2 Siltuximab in Schizophrenia May 2016 December 31, 2023
NCT05445180 Recruiting N/A Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use April 21, 2022 May 2027
NCT05500001 Recruiting N/A Supporting Patients by Family Education in Psychotic Illness: A Prospective Cohort Study September 1, 2022 September 1, 2025
NCT03332966 Recruiting Youth Experiences and Health Study December 1, 2019 December 31, 2024
NCT05501405 Recruiting N/A Brain and Oculometric Markers of Emotional Facial Expression Recognition Deficits March 30, 2022 September 30, 2026
NCT05537376 Recruiting N/A A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness September 12, 2023 October 31, 2027
NCT04756388 Recruiting N/A Examining Strategy Monitoring and Remediation Training February 1, 2021 May 2023
NCT05538832 Recruiting Early Phase 1 Remote State Representation in Early Psychosis July 27, 2022 March 31, 2025
NCT03525054 Recruiting Semantic and Syntactic Computerized Analysis of Free Speech May 18, 2018 June 30, 2024
NCT05562674 Recruiting N/A Impact of VVV Group for Veterans With SMI March 18, 2024 October 31, 2024
NCT04040829 Suspended N/A Cognitive Remediation and Supported Education in Psychotic Disorders September 1, 2021 September 2024
NCT04125030 Suspended Convergent and Concurrent Validity Between Clinical Recovery and Personal-civic Recovery in Mental Health August 5, 2019 October 2020
NCT02505022 Terminated Role Functioning Changes NOS January 2016 January 2021
NCT00725270 Terminated Phase 2/Phase 3 Treatment of Schizoaffective Disorder Using Mifepristone April 1998 May 2009
NCT01324297 Terminated The Topical Niacin Skin Flush Test in First Episode Psychosis December 2011 July 2016
NCT00486798 Terminated Phase 3 FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis May 2007 August 2007
NCT00282165 Terminated Phase 4 Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order November 2006 December 2012
NCT02584114 Terminated N/A Brain Effects of Memory Training in Early Psychosis September 2016 June 2017
NCT00715377 Terminated N/A Anticholinergic Burden in Schizophrenia June 2007 December 2011
NCT00508560 Terminated N/A Contingency Management for Smoking Cessation Among Veterans With Psychotic Disorders July 2007 December 2012
NCT02841956 Terminated N/A Reducing Duration of Untreated Psychosis Through Rapid Identification and Engagement September 2014 March 13, 2020
NCT00183612 Terminated N/A Determining the Safety and Effectiveness of Olanzapine in Children and Adolescents May 2000 April 2007
NCT00287027 Terminated Family Perspectives:Treatment of Psychiatric Illnesses With Atypical Long Acting Injectable Antipsychotic Medication February 2006 December 2006
NCT03230097 Terminated Phase 2 This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year September 29, 2017 April 7, 2021
NCT00457899 Terminated Phase 3 Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disorder July 2007 September 2007
NCT02751632 Unknown status Phase 3 The Staged Treatment in Early Psychosis Study April 2016 May 2021
NCT00465920 Unknown status Phase 2 Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis May 2007 April 2010
NCT00188981 Unknown status Dutch Prediction of Psychosis Study June 2003 June 2008
NCT00541502 Unknown status Improving Cognitive Function of Aripiprazole in Treating Adolescents and Young Adults With Psychotic Disorder November 2007 October 2008
NCT00563017 Unknown status N/A Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone October 2004 November 2005
NCT02848469 Unknown status Phase 2 Irish Omega-3 Study September 2013 February 2018
NCT02873884 Unknown status Impact of Case-management on Therapeutic Alliance With First Episode Psychosis Patients (CAMAT) November 2016 November 2019
NCT03090503 Unknown status Phase 4 Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-up June 2014 June 2021
NCT05405946 Unknown status N/A Computerized Cognitive Remediation Therapy in Adolescents With a First Psychotic Episode March 19, 2019 March 2023
NCT03491852 Unknown status N/A A Novel Treatment Approach for Self-Stigma in First Episode Psychosis April 1, 2018 January 2020
NCT01202357 Unknown status N/A Optimal Duration of Early Intervention for Psychosis July 2010 June 2012
NCT01354236 Unknown status Mental Health Related to School Dropout in Luxembourg January 2011
NCT01423669 Unknown status Epidemiology Study of Psychosis August 2010 December 2013
NCT03807388 Unknown status N/A ReMindCare App for Patients From First Episode of Psychosis Unit. September 2019 September 2023
NCT01752465 Unknown status N/A Is Health Coaching Effective for Improving Metabolic Health in People With Psychosis Disorders? January 2016 September 2016
NCT03883204 Unknown status Phase 4 Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up January 1, 2015 December 2020
NCT01977521 Unknown status N/A Transcranial Direct Current Stimulation as Treatment for Auditory Hallucinations April 2014 February 2018
NCT02009969 Unknown status Serial Comparisons of Abdominal and Neurological MRI Scans September 2013 January 2017
NCT00071604 Unknown status N/A Medication Adherence in Older People With Psychosis September 2002 May 2007
NCT04239612 Unknown status N/A Fitforlife- Exercise in Care of Psychosis January 21, 2020 December 31, 2022
NCT02095457 Unknown status N/A Routine Outcome Monitoring in Mental Health Outpatient July 2014
NCT02137616 Unknown status N/A Antipsychotic to Treat Psychosis Syndrome June 2012 December 2014
NCT04445324 Unknown status N/A Effects of Online and Recovery-oriented Peer Support Groups Facilitated by Peer Support Workers in Times of COVID-19 August 25, 2020 December 2020
NCT00157313 Unknown status N/A Clinical Trial of Integrated Treatment Versus Standard Treatment in First Episode Psychosis January 1998 December 2022
NCT02532491 Unknown status Phase 4 Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-up May 2014 December 2020
NCT00276263 Withdrawn Phase 2 Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia August 2006 June 2009
NCT04415541 Withdrawn N/A Psychodynamic Psychotherapy for Psychosis May 2021 August 2021
NCT02286206 Withdrawn Phase 4 Study of the Effect of Dosing on Clozapine Levels January 2015 December 2017
NCT02213887 Withdrawn Phase 4 Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications September 2014 November 2, 2020